Skip to main content

CORRECTION article

Front. Mol. Biosci., 13 October 2022
Sec. Nanobiotechnology
Volume 9 - 2022 | https://doi.org/10.3389/fmolb.2022.1046852

Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies

This article is a correction to:

  1. Editorial: Advanced nanotechnology for reactive oxygen species-mediated therapies

    1. Read original article
Chun Gwon Park,Chun Gwon Park1,2Wonhwa LeeWonhwa Lee3Dong-Hyun Kim,,,Dong-Hyun Kim4,5,6,7Fangyuan Li,Fangyuan Li8,9Wooram Park Wooram Park10*
  • 1Department of Biomedical Engineering, SKKU Institute for Convergence, Sungkyunkwan University, Suwon, South Korea
  • 2Department of Intelligent Precision Healthcare Convergence, SKKU Institute for Convergence, Sungkyunkwan University, Suwon, South Korea
  • 3Department of Chemistry, Sungkyunkwan University, Suwon, South Korea
  • 4Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, IL, United States
  • 5Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, United States
  • 6Department of Biomedical Engineering, McCormick School of Engineering, Evanston, IL, United States
  • 7Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, United States
  • 8College of Pharmaceutical Sciences, Institute of Pharmaceutics, Zhejiang University, Hangzhou, China
  • 9College of Pharmaceutical Sciences, Hangzhou Institute of Innovative Medicine, Zhejiang University, Hangzhou, China
  • 10Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Suwon, South Korea

A Corrigendum on
Editorial: Advanced nanotechnology for reactive oxygen species-mediated therapies

by Park CG, Lee W, Kim D-H, Li F and Park W (2022). Front. Mol. Biosci. 9:1000113. doi: 10.3389/fmolb.2022.1000113

In the published article, an author name was incorrectly written as “Wonhaw Lee.” The correct spelling is “Wonhwa Lee.”

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: reactive oxygen species (ROS), nanotechnology, disease treatment and diagnosis, pyroptosis, aging

Citation: Park CG, Lee W, Kim D-H, Li F and Park W (2022) Corrigendum: Editorial: Advanced nanotechnology for reactive oxygen species‐mediated therapies. Front. Mol. Biosci. 9:1046852. doi: 10.3389/fmolb.2022.1046852

Received: 17 September 2022; Accepted: 20 September 2022;
Published: 13 October 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Park, Lee, Kim, Li and Park. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wooram Park, cGFya3dyQHNra3UuZWR1

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.